Allergan (AGN +2.5%) shares jump following news that the FDA approves Botox to treat urinary...

|About: Allergan plc (AGN)|By:, SA News Editor

Allergan (AGN +2.5%) shares jump following news that the FDA approves Botox to treat urinary incontinence in people with neurologic conditions such as spinal cord injury and multiple sclerosis who have overactivity of the bladder.